• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].

作者信息

Płaczek Marcin, Jacyna Julia, Sznitowska Małgorzata

机构信息

Department of Pharmaceutical Technology, Medical University of Gdańsk, Poland.

出版信息

Pol Merkur Lekarski. 2013 Dec;35(210):391-6.

PMID:24490472
Abstract

The article presents description of the most important parenteral forms, which release an active substance in sustained manner. Technological and biopharmaceutical information is supplemented with examples of commercial products, currently registered in Poland. Mechanism of drug release from the dosage form and duration of the process, role of other excipients and characteristics of certain medicinal products is presented. The information about suspensions and oily solutions for injection is summarized. Owing to specific chemical modifications and selection of suitable excipients, it was possible to develop these types of medicinal products for some antibiotics, hormones, antipsychotics and cytostatics. These formulations, after subcutaneous or intramuscular injection, release the active substances even for several weeks allowing to reduce the frequency of drug administration and finally help to improve patient's compliance. Here also the modified time course of insulin products achieved by selection of appropriate suspension form or insulin analogue is discussed.

摘要

相似文献

1
[Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
Pol Merkur Lekarski. 2013 Dec;35(210):391-6.
2
[Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].[用于肠胃外给药的缓释药物制剂。第二部分。注射用微球和植入剂]
Pol Merkur Lekarski. 2014 Jan;36(211):54-8.
3
Role of in vitro release models in formulation development and quality control of parenteral depots.在注射用储库制剂的开发和质量控制中,体外释放模型的作用。
Expert Opin Drug Deliv. 2009 Dec;6(12):1283-95. doi: 10.1517/17425240903307431.
4
Sustained release veterinary parenteral products.缓释型兽用注射剂产品
Adv Drug Deliv Rev. 2004 Jun 23;56(10):1345-65. doi: 10.1016/j.addr.2004.02.005.
5
[Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].[双氯芬酸钠缓释制剂中所选药物的技术和药物治疗特性]
Polim Med. 2012;42(2):121-32.
6
Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
Eur J Pharm Biopharm. 2004 Nov;58(3):587-93. doi: 10.1016/j.ejpb.2004.04.002.
7
[The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].[天然及合成亲水性聚合物在不同释放曲线盐酸二甲双胍片制剂中的应用]
Polim Med. 2012;42(3-4):167-84.
8
In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.控释注射剂的体外溶出方法及其在药物洗脱支架检测中的适用性。
J Pharm Pharmacol. 2012 Jul;64(7):969-85. doi: 10.1111/j.2042-7158.2011.01439.x. Epub 2012 Feb 7.
9
Novel oral suspensions: a review.新型口服混悬剂:综述
Curr Drug Deliv. 2014;11(3):338-58. doi: 10.2174/1567201811666140113114926.
10
Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.制剂参数对长效注射混悬剂体外释放的影响。
AAPS J. 2021 Mar 11;23(2):42. doi: 10.1208/s12248-021-00566-0.

引用本文的文献

1
Continuous Microfluidic Antisolvent Crystallization as a Bottom-Up Solution for the Development of Long-Acting Injectable Formulations.连续微流控抗溶剂结晶作为长效注射剂配方开发的自下而上解决方案。
Pharmaceutics. 2024 Mar 8;16(3):376. doi: 10.3390/pharmaceutics16030376.